PureTech Health PLC Transaction in Own Shares (5456Q)
June 29 2022 - 2:00AM
UK Regulatory
TIDMPRTC
RNS Number : 5456Q
PureTech Health PLC
29 June 2022
29 June 2022
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has
purchased the following number of its ordinary shares of one pence
each through Jefferies International Limited ("Jefferies"), as part
of its Share Buyback Programme, details of which were announced on
9 May 2022.
Date of purchase: 28 June 2022
Number of ordinary shares purchased: 3,432
Highest price paid per share: 171.60p
Lowest price paid per share: 171.60p
Volume weighted average price paid per
share: 171.60p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 1,737,780
ordinary shares in treasury and has 286,873,340 ordinary shares in
issue (excluding treasury shares). The total number of voting
rights in the Company is therefore 286,873,340, which may be used
by shareholders in their calculations to determine if they are
required to notify their interest in, or a change to their interest
in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No
596/2014 (as incorporated into UK domestic law by the European
Union (Withdrawal) Act 2018) (the Market Abuse Regulation),
detailed information about the individual purchases is available
below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated
to discovering, developing and commercializing highly
differentiated medicines for devastating diseases, including
inflammatory, fibrotic and immunological conditions, intractable
cancers, lymphatic and gastrointestinal diseases and neurological
and neuropsychological disorders, among others. The Company has
created a broad and deep pipeline through the expertise of its
experienced research and development team and its extensive network
of scientists, clinicians and industry leaders.
This pipeline, which is being advanced both internally and
through PureTech's Founded Entities, is comprised of 27
therapeutics and therapeutic candidates, including two that have
received both U.S. FDA clearance and European marketing
authorization, as of the date of PureTech's most recently filed
Annual Report and corresponding Form 6-K. All of the underlying
programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and
then advanced by the PureTech team through key validation points
based on unique insights in immunology and drug development.
For more information, visit www.puretechhealth.com or connect
with us on Twitter @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Transaction Transaction Volume Price Platform Transaction Reference
Date Time (GBp) Number
28/06/2022 16:29:44 108 171.6 XLON 00307483464TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 16:29:44 243 171.6 XLON 00307483462TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 16:29:44 33 171.6 XLON 00307483459TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 16:29:44 198 171.6 XLON 00307483429TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 16:29:44 464 171.6 XLON 00307483430TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 15:32:55 32 171.6 XLON 00307453417TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 15:13:25 52 171.6 AQXE 00307443713TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 15:13:25 58 171.6 AQXE 00307443711TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 15:13:25 56 171.6 AQXE 00307443709TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 15:13:25 59 171.6 AQXE 00307443707TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 15:13:25 60 171.6 AQXE 00307443705TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 15:13:25 58 171.6 AQXE 00307443703TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 15:13:25 66 171.6 AQXE 00307443701TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 15:13:25 58 171.6 AQXE 00307443699TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 15:13:25 57 171.6 AQXE 00307443697TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 15:13:25 60 171.6 AQXE 00307443695TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 15:13:25 55 171.6 AQXE 00307443693TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 15:13:25 55 171.6 AQXE 00307443690TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 15:13:25 55 171.6 AQXE 00307443688TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 15:13:25 55 171.6 AQXE 00307443686TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 14:45:16 377 171.6 XLON 00307427534TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 14:45:16 47 171.6 XLON 00307427529TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 13:00:15 53 171.6 XLON 00307389673TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 13:00:15 236 171.6 XLON 00307389671TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 12:43:04 110 171.6 XLON 00307384195TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 09:57:40 79 171.6 XLON 00307312365TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 08:43:20 242 171.6 XLON 00307274031TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 08:29:36 74 171.6 XLON 00307264129TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 08:18:39 105 171.6 XLON 00307256199TRLO1.1.1
------------ ------- ------- --------- ----------------------
28/06/2022 08:10:00 227 171.6 XLON 00307249707TRLO1.1.1
------------ ------- ------- --------- ----------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
POSFLFSDRIITFIF
(END) Dow Jones Newswires
June 29, 2022 02:00 ET (06:00 GMT)
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jul 2023 to Jul 2024
